focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.20
Bid: 51.20
Ask: 51.40
Change: -0.20 (-0.39%)
Spread: 0.20 (0.391%)
Open: 51.50
High: 52.10
Low: 51.10
Prev. Close: 51.40
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio co Ceres finalises deal with Weichai

4 Dec 2018 17:49

RNS Number : 4464J
IP Group PLC
04 December 2018
 

FOR RELEASE ON

04 December 2018

 

IP Group plc - Portfolio company Ceres Power finalises strategic collaboration with Weichai; further £28m investment

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, is pleased to note that portfolio company Ceres Power Holdings plc ("Ceres", "Ceres Power" or "the Company") and Weichai Power ("Weichai"), one of the leading automobile and equipment manufacturing companies in China, have agreed a long-term strategic collaboration.

 

The agreement, which triggers a further £28m equity injection into Ceres Power, includes a Joint Venture Agreement with the commitment to create a fuel cell manufacturing JV in China, a License Agreement to transfer key technology to the JV and a new £9 million joint development agreement.

 

Prior to the new equity investment by Weichai, IP Group currently holds a direct undiluted beneficial stake of 21.3% in Ceres, developer of the SteelCell®, a world-leading, low cost Solid Oxide Fuel Cell technology.

 

Dr Robert Trezona, Head of Cleantech at IP Group, said: "Ceres Power continues to make excellent commercial progress, having signed agreements with Weichai and Bosch this year. The Company is also well funded having completed a significantly oversubscribed £20m fundraising in July as well as having agreed a combined £57m of new investment from Weichai and Bosch. Since IP Group's investment in Ceres in 2012, the Company has gone from strength to strength and is a great example of how we've helped to create a world-leading company based on scientific research carried out in the UK."

 

The highlights of Ceres' announcement are:

 

- A new Joint Development Agreement (JDA) worth £9m to Ceres for the continued development of a first range extender product for electric buses in China.

- A Joint Venture Agreement for Ceres and Weichai to invest in a major new fuel cell manufacturing facility in Shandong, China, following successful trials.

- A License Agreement which will result in significant staged Technology Transfer payments of up to £30m, and ongoing future royalties to Ceres.

- Weichai will invest a further £28m in Ceres through the exercise of its warrant at 164.5p per share to increase its stake in Ceres from just under 10% to 20%. This brings its total equity investment in Ceres to £48m.

 

Ceres has completed a number of collaborations this year including a strategic collaboration with Robert Bosch GmbH as well as a £9m strategic equity investment by Bosch into Ceres in August. Prior to that, Ceres signed a new partnership with Nissan to further develop fuel cell technology for EV applications which saw Ceres and The Welding Institute awarded a total of £8m UK Government funding through the Advanced Propulsion Centre for the project.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive OfficerGreg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

Andrew Wilson

+44 (0) 7810 636995

Martha Walsh

+44 (0) 7876 245962

Tom Gillingham

+44 (0) 7741 659021

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

Group holdings in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUGGQCPUPRGMC
Date   Source Headline
15th Jan 20245:49 pmRNSTransaction in Own Shares
12th Jan 20246:27 pmRNSTransaction in Own Shares
11th Jan 20245:32 pmRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20245:13 pmRNSTransaction in Own Shares
8th Jan 20245:20 pmRNSTransaction in Own Shares
5th Jan 20245:02 pmRNSTransaction in Own Shares
4th Jan 20245:48 pmRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
22nd Dec 20237:10 amRNSTop 20 portfolio company funding round
20th Dec 20236:20 pmRNSTransaction in Own Shares
19th Dec 20235:44 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSShare buyback programme
14th Nov 20237:11 amRNSAutifony signs deal with Jazz for up to $770m
26th Oct 20236:10 pmRNSHolding(s) in Company
12th Oct 202310:20 amRNSWebinar on ESG & Impact
28th Sep 20234:28 pmRNSDirector/PDMR Shareholding; SAYE scheme
8th Aug 202310:00 amRNSTechnology trends webinar on AI
2nd Aug 20237:00 amRNSIP Group half-yearly results
13th Jul 20235:11 pmRNSDirector Declaration
12th Jul 20231:41 pmRNSTR-1: form for notification of major holdings
30th Jun 202310:23 amRNSTotal Voting Rights
29th Jun 20236:24 pmRNSDirector/PDMR Shareholding
28th Jun 202311:31 amRNSNotice of Results
26th Jun 202312:41 pmRNSDirector Declaration
15th Jun 20231:19 pmRNSResult of AGM
15th Jun 20237:00 amRNSAGM Statement
8th Jun 20238:51 amRNSLife Sciences update event
7th Jun 202311:00 amRNSIP Group plc - TR1 form
31st May 20232:34 pmRNSTotal Voting Rights
12th May 20231:26 pmRNSDirector Declaration
10th May 202312:11 pmRNSDirector/PDMR Shareholding
3rd May 202310:56 amRNSDirector Declaration
28th Apr 20233:21 pmRNSTotal Voting Rights
20th Apr 20235:00 pmRNSNotice of AGM, Annual Report
18th Apr 20233:23 pmRNSRSP & DBSP awards; Director/PDMR shareholding
15th Mar 20239:31 amRNSInvestor presentation
13th Mar 20239:00 amRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNSNo direct deposits or credit facilities with SVB
8th Mar 20237:00 amRNSIP Group plc - Annual Results
2nd Mar 20233:25 pmRNSTR-1
21st Feb 20237:00 amRNSAMSL Aero's all-electric aircraft maiden flight
10th Feb 20239:55 amRNSNotice of Results
31st Jan 202310:00 amRNSTotal Voting Rights
30th Jan 20237:00 amRNSStatement re press speculation
24th Jan 20231:18 pmRNSForm 8.3 - Mirriad Advertising plc
18th Jan 20237:00 amRNSDirectorate Change
11th Jan 20237:00 amRNSPortfolio company Oxbotica raises $140m Series C

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.